Offer - Urjas Oil for just ₹ 1 X
Pramipex ER 1.25 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Parkinson's Disease. The alternative uses of Pramipex ER 1.25 Tablet have also been explained below.
The right dosage of Pramipex ER 1.25 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Pramipex ER 1.25 Tablet can also lead to other problems, which have been listed below. Such side effects of Pramipex ER 1.25 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Pramipex ER 1.25 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. In addition, Pramipex ER 1.25 Tablet's effects on the liver, heart and kidney are discussed below in the Pramipex ER 1.25 Tablet related warnings section.
Pramipex ER 1.25 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Pramipex ER 1.25 Tablet in conditions like Schizophrenia, Heart Disease, Kidney Disease.
Additionally, Pramipex ER 1.25 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Pramipex ER 1.25 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Pramipex ER 1.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pramipex ER 1.25 Tablet safe for pregnant women?
Pramipex can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Pramipex right away. Take your doctor's advice before taking it again.
Is the use of Pramipex ER 1.25 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Pramipex. It should only be taken after medical advice.
What is the effect of Pramipex ER 1.25 Tablet on the Kidneys?
Pramipex rarely harms the kidneys.
What is the effect of Pramipex ER 1.25 Tablet on the Liver?
There are no any side effects of Pramipex on the liver.
What is the effect of Pramipex ER 1.25 Tablet on the Heart?
Pramipex has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Pramipex ER 1.25 Tablet unless your doctor advises you to do so -
Is this Pramipex ER 1.25 Tablet habit forming or addictive?
Forming a habit of Pramipex ER 1.25 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Pramipex ER 1.25 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Pramipex ER 1.25 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, this Pramipex ER 1.25 Tablet works for mental disorders.
Interaction between Food and Pramipex ER 1.25 Tablet
Taking Pramipex ER 1.25 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Pramipex ER 1.25 Tablet
Consult your doctor before consuming alcohol while taking Pramipex ER 1.25 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431